SHJBF (Shanghai Junshi Biosciences Co) ROCE %: -10.26% (As of Dec. 2025)


SHJBF Shanghai Junshi Biosciences Co Ltd SHJBF
66 GF Score
Price $3.35
GF Value $6.14
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co ROCE %?

Shanghai Junshi Biosciences Co SHJBF +11.67% 66 ROCE % is -10.26% as of Dec. 2025. GuruFocus rates SHJBF with a GF Score™ of 66/100 and a GF Value™ of $6.14 (Possible Value Trap). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Junshi Biosciences Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -10.26%.

Shanghai Junshi Biosciences Co  (OTCPK:SHJBF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Junshi Biosciences Co ROCE % Related Terms

Shanghai Junshi Biosciences Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shanghai Junshi Biosciences Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Junshi Biosciences Co ROCE % Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.42 -25.58 -24.67 -15.09 -10.37

Shanghai Junshi Biosciences Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.67 -14.92 -15.25 -10.62 -10.26
SHJBF
66GF Score
Shanghai Junshi Biosciences Co Ltd SHJBF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Junshi Biosciences Co ROCE % Calculation

Shanghai Junshi Biosciences Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-129.458/( ( (1483.386 - 348.061) + (1760.419 - 399.247) )/ 2 )
=-129.458/( (1135.325+1361.172)/ 2 )
=-129.458/1248.2485
=-10.37 %

Shanghai Junshi Biosciences Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-131.914/( ( (1628.458 - 418.314) + (1760.419 - 399.247) )/ 2 )
=-131.914/( ( 1210.144 + 1361.172 )/ 2 )
=-131.914/1285.658
=-10.26 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -10.26% mean?
Shanghai Junshi Biosciences Co (SHJBF) has a ROCE % of -10.26% as of Dec. 2025.
Is Shanghai Junshi Biosciences Co's ROCE % too high?
Shanghai Junshi Biosciences Co's current ROCE % is -10.26%. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's ROCE % compare to VRTX and REGN?
Shanghai Junshi Biosciences Co's ROCE % of -10.26% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Shanghai Junshi Biosciences Co's current ROCE % is -10.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co (SHJBF) is currently considered Possible Value Trap. The stock's GF Value™ is $6.14, compared to a current price of $3.35 — trading 45.4% below its estimated fair value. The current ROCE % is -10.26%. Shanghai Junshi Biosciences Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (SHJBF), the current ROCE % is -10.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (SHJBF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of $3.35 is trading 45.4% below its estimated GF Value™ of $6.14. GuruFocus considers Shanghai Junshi Biosciences Co to be Possible Value Trap.

Key valuation signals for SHJBF:

  • ROCE %: -10.26%
  • GF Value™: $6.14 vs. price of $3.35 (45.4% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the SHJBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Junshi Biosciences Co Business Description

Other Exchanges 01877:Hong Kong688180:China
Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
66GF Score

Get the complete analysis for SHJBF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$6.14
GF Value